Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LH | Common Stock | Options Exercise | +237 | +4.44% | 5.58K | Feb 2, 2023 | Direct | F1, F2 | ||
transaction | LH | Common Stock | Tax liability | -$16.3K | -64 | -1.15% | $254.99 | 5.51K | Feb 2, 2023 | Direct | F2, F3 |
transaction | LH | Common Stock | Sale | -$43.9K | -173 | -3.14% | $253.90 | 5.34K | Feb 3, 2023 | Direct | F2, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LH | Restricted Stock Unit | Options Exercise | $0 | -237 | -14.42% | $0.00 | 1.41K | Feb 2, 2023 | Common Stock | 237 | Direct | F1, F5, F6 |
Id | Content |
---|---|
F1 | Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
F2 | Amount includes 26.2103 shares acquired on June 30, 2022 and 27.5309 shares acquired on December 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. |
F3 | Stock withholding to satisfy tax withholding obligations. |
F4 | Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. |
F5 | The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022. |
F6 | This number reflects the aggregate number of Restricted Stock Units held by the reporting person. |